SLC18A2

gene product
SVAT, SVMT, VMAT2
The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (summary by Peter et al., 1993 [PubMed 7905859]). See also SLC18A1 (MIM 193002). [supplied by OMIM, Jan 2011]
More gene data

Featured antibodies

Antibodies

 

Filters

Knockdown Initiative

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated in Knockdown Initative
Eligible for validation in KDI
127 antibodies from 21 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeKDWBELICCIPIHCFC
Novus Biologicals
17 antibodies
OriGene
5 antibodies
GeneTex
4 antibodies
antibodies-online
50 antibodies
Acris Antibodies GmbH
5 antibodies
Biorbyt
5 antibodies
Everest Biotech
1 antibody
Aviva Systems Biology
3 antibodies
Atlas Antibodies
1 antibody
LifeSpan BioSciences, Inc.
15 antibodies
Bioworld Technology, Inc
1 antibody
Abnova Corporation
2 antibodies
Proteintech Group
1 antibody
Rockland Immunochemicals, Inc.
1 antibody
Abgent
1 antibody
EMD Millipore
1 antibody
Sigma-Aldrich
4 antibodies
Thermo Fisher Scientific Pierce
4 antibodies
Creative Diagnostics
4 antibodies
PhosphoSolutions
1 antibody
United States Biological
1 antibody